Swedbank
INDV icon

Swedbank’s Indivior Pharmaceuticals INDV Stock Holding History

Swedbank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.98M Sell
222,600
-26,400
-11% -$997K 0.01% 530
2026
Q2 		$10.2M Buy
249,000
+154,000
+162% +$5.59M 0.01% 513
2026
Q1 		$2.9M Buy
+95,000
New +$3.14M ﹤0.01% 611

Other funds holding INDV

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Swedbank's INDV Position: Q3 2026 in Review

Swedbank reduced its Indivior Pharmaceuticals (INDV) stake by 11% in Q3 2026, selling an estimated $997K and leaving 222,600 shares worth $7.98M. The position accounts for 0.01% of the portfolio, ranked #530.

Swedbank first reported a position in INDV in Q1 2026 and has held it in 3 quarters since. The position peaked at $10.2M in Q2 2026. 76 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • Swedbank held 222,600 shares of Indivior Pharmaceuticals worth $7.98M as of Q3 2026.
  • Swedbank sold 26,400 Indivior Pharmaceuticals shares in Q3 2026, an estimated $997K.
  • Indivior Pharmaceuticals made up 0.01% of Swedbank's portfolio in Q3 2026, its #530 holding.
  • Swedbank first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Swedbank's Indivior Pharmaceuticals position peaked at $10.2M in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.